Lipella Pharmaceuticals Inc. (LIPO) Operating margin 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) operating margin by fiscal year — reported operating income divided by reported revenue.
-947.2%FY2024 · since FY2021: -738.7% → -947.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -947.2% | +108.3 pp |
| FY2023 | -1055.6% | +350.7 pp |
| FY2022 | -1406.3% | -667.5 pp |
| FY2021 | -738.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice